Amsterdam UMC

Amsterdam UMC is active in oncology and hematology, with trials focused on cancers such as breast cancer, cervical cancer, lung cancer, esophageal cancer, and blood cancers including lymphoma, multiple myeloma, and leukemia. The research is aimed at testing new treatment options, improving outcomes, and comparing therapies to find more effective approaches for patients.

• New treatment strategies for solid tumors and blood cancers
• Studies in relapsed, refractory, and advanced disease settings
• Comparisons of combination therapies and standard care

Much of this work at Amsterdam UMC is designed to broaden options for patients with difficult-to-treat cancers while improving disease control and survival.

The Gynaecology department leads research in female urogenital diseases and pregnancy-related conditions, including studies in cervical cancer and unexplained recurrent miscarriages. These trials explore fertility-preserving care, better treatment planning, and ways to improve reproductive outcomes.

• Fertility-sparing approaches in cervical cancer
• Therapies for recurrent miscarriage in early pregnancy
• Clinical strategies that balance cancer control and quality of life

Research in this area reflects a strong focus on treatment effectiveness while also considering long-term well-being and family planning.

Clinical trials at this site also cover cardiovascular diseases and blood-clot related conditions, including acute myocardial infarction, atrial fibrillation, stroke prevention, and heterozygous familial hypercholesterolemia. The goal is to evaluate safer and more effective ways to prevent serious cardiovascular events and reduce risk.

• Prevention of stroke and systemic embolism
• Management of acute and recurrent myocardial infarction
• Lowering cardiovascular risk through improved lipid control

These studies combine treatment testing with prevention research to support better long-term heart and vessel health.

Amsterdam UMC is conducting trials in respiratory tract diseases such as severe asthma, pulmonary arterial hypertension, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, cystic fibrosis bronchiectasis, and pneumonia. These studies aim to improve symptom control, slow disease progression, and test new therapies for chronic and acute lung conditions.

• New treatments for severe and progressive lung disease
• Approaches to reduce breathing difficulties and exacerbations
• Support for patients with chronic and inflammatory respiratory conditions

The research spans both long-term lung disorders and hospital-based infections, reflecting a broad interest in pulmonary care.

The site has an active portfolio in nervous system diseases, including Parkinson’s disease, mild cognitive impairment, dementia, leukoencephalopathy, and rare inherited neurological disorders. These trials are designed to test new therapies, understand disease progression, and improve diagnosis and monitoring.

• Therapy development for progressive neurological conditions
• Research on cognitive decline and movement disorders
• Evaluation of diagnostic tools and biomarkers

This work supports earlier recognition of disease and better treatment options for patients with complex neurological needs.

Research in digestive system diseases includes ulcerative colitis, Crohn’s disease, chronic pancreatitis, functional constipation, and esophageal cancer. Trials in this area focus on improving symptom relief, reducing inflammation, and evaluating new treatment strategies for both chronic and severe gastrointestinal conditions.

• Inflammatory bowel disease treatment research
• Pain management in chronic pancreatitis
• Testing therapies for digestive disorders and GI cancers

The studies aim to improve daily functioning and clinical outcomes across a wide range of gastrointestinal diseases.

Amsterdam UMC also studies immune system diseases, congenital and hereditary conditions, and other rare disorders such as systemic sclerosis, ADPKD, hemophilia A, thalassemia, and selected inherited neurological diseases. The research is centered on testing novel therapies, improving disease control, and understanding long-term effects in uncommon conditions.

• Rare disease treatment evaluation
• Genetic and inherited disorder research
• Studies aimed at slowing progression and reducing complications

These trials are especially important for patients with limited treatment options and complex, lifelong conditions.

Beyond disease-specific trials, the site is advancing diagnosis and investigative techniques through studies that assess imaging and other clinical tools. Research includes efforts to improve cancer staging and diagnostic accuracy, helping clinicians make better-informed treatment decisions.

• Improving diagnostic precision in cancer care
• Evaluating imaging methods for staging and restaging
• Supporting better patient management through more accurate tests

This area highlights a strong interest in tools that can guide treatment selection and refine clinical practice.

Trial activity also includes nutritional and metabolic diseases and related internal medicine topics such as cholesterol disorders, pancreatic disease, and pulmonary complications linked to systemic illness. These studies are generally focused on testing therapies that may improve disease control, reduce complications, and support overall health.

• Management of metabolic and lipid-related risk
• Therapy testing in complex chronic disease settings
• Research aimed at preventing complications and improving quality of life

At Amsterdam UMC, this broad internal medicine portfolio complements the site’s more specialized disease programs.

Some studies address psychological phenomena and patient-centered outcomes, including quality of life, treatment burden, and everyday functioning. These projects often accompany clinical treatment trials and help determine whether new approaches are not only effective, but also acceptable and practical for patients.

• Assessing quality of life alongside clinical benefit
• Understanding treatment tolerability and patient experience
• Supporting more practical and patient-friendly care

This reflects a broader commitment to research that considers both medical results and the lived experience of patients.